Abstract | BACKGROUND AND AIMS: METHODS: The rats were divided into 7-8 groups receiving vehicle, esomeprazole, and different doses of intravenous and enteral ilaprazole. The rats were then exposed to indomethacin (30 mg/kg, i.g.), or water-immersion stress and gastric lesions were examined. The effects of different treatments on histamine (10 μmol/kg/h)-induced acid secretion were also observed. RESULTS: Intravenous ilaprazole exhibited high antiulcer activity in a dose-dependent manner. Ilaprazole at a dose of 3 mg/kg decreased ulcer number and index to the same extent as 20 mg/kg esomeprazole. Moreover, the potency of intravenous ilaprazole is superior to that of intragastric ilaprazole. In anesthetized rats, the inhibitory effect of intravenous ilaprazole on histamine-induced acid secretion is faster and longer-lasting than that of intraduodenal ilaprazole. CONCLUSION:
|
Authors | Gang Yu, Xin-Qiang Lu, Rui-Bin Su, Ze-Hui Gong, He-Zhi Xie, Hai-Tang Hu, Xue-Mei Hou |
Journal | Digestive diseases and sciences
(Dig Dis Sci)
Vol. 59
Issue 10
Pg. 2417-22
(Oct 2014)
ISSN: 1573-2568 [Electronic] United States |
PMID | 24801687
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- 2-Pyridinylmethylsulfinylbenzimidazoles
- Anti-Inflammatory Agents, Non-Steroidal
- Gastrointestinal Agents
- ilaprazole
- Histamine
- Indomethacin
|
Topics |
- 2-Pyridinylmethylsulfinylbenzimidazoles
(administration & dosage, therapeutic use)
- Animals
- Anti-Inflammatory Agents, Non-Steroidal
(toxicity)
- Gastric Acid
(metabolism)
- Gastric Mucosa
(metabolism)
- Gastrointestinal Agents
(administration & dosage, therapeutic use)
- Histamine
(pharmacology)
- Indomethacin
(toxicity)
- Male
- Rats
- Rats, Sprague-Dawley
- Stomach
(drug effects, pathology)
- Stomach Ulcer
(drug therapy)
- Stress, Physiological
|